This shows you the differences between two versions of the page.
Both sides previous revision Previous revision Next revision | Previous revision | ||
bacteria:t3e:xoph [2020/06/30 18:38] rkoebnik [References] |
bacteria:t3e:xoph [2020/10/28 12:20] (current) rkoebnik [XopH] |
||
---|---|---|---|
Line 2: | Line 2: | ||
Author: Isabel Rodrigues\\ | Author: Isabel Rodrigues\\ | ||
- | Internal reviewer: | + | Internal reviewer: |
Expert reviewer: FIXME | Expert reviewer: FIXME | ||
Class: XopH\\ | Class: XopH\\ | ||
Family: XopH\\ | Family: XopH\\ | ||
- | Prototype: XopH (// | + | Prototype: XopH (// |
RefSeq ID: [[https:// | RefSeq ID: [[https:// | ||
- | 3D structure: [[https:// | + | Synonym: AvrBs1.1\\ |
+ | 3D structure: [[https:// | ||
===== Biological function ===== | ===== Biological function ===== | ||
=== How discovered? === | === How discovered? === | ||
- | The XopH effector, also known as AvrBs1.1 (White //et al//., 2009), was discovered due to its virulent activity (Gurenn //et al//., 2006). Later, this effector began to be identified based on the coregulation with the TTS system (Gurenn //et al//., 2006), most recently began to be identified by a combination of biochemical approaches, including a new NMR-based method to discriminate inositol polyphosphate enantiomers (Blüher //et al//., 2017). | ||
+ | The XopH effector, also known as AvrBs1.1 (White //et al//., 2009), was first reported in 1988 (Ronald and Staskawicz 1988) and discovered due to its virulent activity (Gurenn //et al//., 2006). Later, this effector began to be identified based on the coregulation with the TTS system (Gurlebeck //et al//., 2006), most recently began to be identified by a combination of biochemical approaches, including a new NMR-based method to discriminate inositol polyphosphate enantiomers (Blüher //et al//., 2017). | ||
=== (Experimental) evidence for being a T3E === | === (Experimental) evidence for being a T3E === | ||
- | The effector XopH, inhibited flg22-induced callose deposition //in planta// (Popov //et al//., 2016), dephosphorylates myo- inositol-hexakisphosphate (phytate, InsP6) //in vitro// and //in vivo// and enhanced disease symptoms (Blüher //et al//., 2017). | ||
+ | The effector XopH, inhibited flg22-induced callose deposition //in planta// (Popov //et al//., 2016), dephosphorylates myo- inositol-hexakisphosphate (phytate, InsP6) to produce InsP5[1-OH], | ||
=== Regulation === | === Regulation === | ||
+ | |||
Unknown. | Unknown. | ||
=== Phenotypes === | === Phenotypes === | ||
- | This effector can inhibit flg22- but not ABA-inducible reporter gene activation in protoplasts act as PTI inhibitors in planta and contribute to development of disease symptoms like chlorosis (Popov //et al//., 2016). XopH liberates phosphate from the plant tissue to improve the nutritional status of the pathogen what causes the plant show obvious symptoms of phosphorus deficiency (Blüher //et al//., 2017). Transgenic //Nicotiana benthamiana// | ||
+ | This effector can inhibit flg22- but not ABA-inducible reporter gene activation in protoplasts act as PTI inhibitors in planta and contribute to development of disease symptoms like chlorosis (Popov //et al//., 2016). XopH liberates phosphate from the plant tissue to improve the nutritional status of the pathogen what causes the plant show obvious symptoms of phosphorus deficiency (Blüher //et al//., 2017). Transgenic //Nicotiana benthamiana// | ||
=== Localization === | === Localization === | ||
- | The effector XopH is localized in the nucleus and in the cytoplasm of the plant cell (Popov //et al//., 2016; Blüher //et al//., 2017). | ||
+ | The effector XopH is localized in the nucleus and in the cytoplasm of the plant cell (Popov //et al//., 2016; Blüher //et al//., 2017). | ||
=== Enzymatic function === | === Enzymatic function === | ||
- | XopH is a T3E with phytate-degrading activity, //in vitro// and //in planta// (Blüher //et al//., 2017). | ||
+ | XopH is a T3E with phytate-degrading activity, //in vitro// and //in planta// (Blüher //et al//., 2017). | ||
=== Interaction partners === | === Interaction partners === | ||
+ | |||
Unknown. | Unknown. | ||
Line 38: | Line 40: | ||
=== In xanthomonads === | === In xanthomonads === | ||
- | Yes (//e.g. Xanthomonas campestris pv. campestris// | ||
+ | Yes (//e.g. Xanthomonas campestris pv. campestris// | ||
=== In other plant pathogens/ | === In other plant pathogens/ | ||
+ | |||
Unknown. | Unknown. | ||
Line 47: | Line 50: | ||
Blüher D, Laha D, Thieme S, Hofer A, Eschen-Lippold L, Masch A, Balcke G, Pavlovic I, Nagel O, Schonsky A, Hinkelmann R, Wörner J, Parvin N, Greiner R, Weber S, Tissier A, Schutkowski M, Lee J, Jessen H, Schaaf G, Bonas U (2017). A 1-phytase type III effector interferes with plant hormone signaling. Nat. Commun. 8: 2159. DOI: [[http:// | Blüher D, Laha D, Thieme S, Hofer A, Eschen-Lippold L, Masch A, Balcke G, Pavlovic I, Nagel O, Schonsky A, Hinkelmann R, Wörner J, Parvin N, Greiner R, Weber S, Tissier A, Schutkowski M, Lee J, Jessen H, Schaaf G, Bonas U (2017). A 1-phytase type III effector interferes with plant hormone signaling. Nat. Commun. 8: 2159. DOI: [[http:// | ||
- | Gurenn | + | Gurlebeck |
+ | |||
+ | Hajri A, Pothier JF, Fischer-Le Saux M, Bonneau S, Poussier S, Boureau T, Duffy B, Manceau C (2011). Type three effector gene distribution and sequence analysis provide new insights into the pathogenicity of plant-pathogenic // | ||
Popov G, Fraiture M, Brunner F, Sessa G (2016). Multiple // | Popov G, Fraiture M, Brunner F, Sessa G (2016). Multiple // | ||
- | Potnis N, Minsavage G, Smith J K, Hurlbert J C, Norman D, Rodrigues R, Stall R E, Jones JB (2012). Avirulence proteins AvrBs7 from // | + | Potnis N, Minsavage G, Smith J K, Hurlbert J C, Norman D, Rodrigues R, Stall R E, Jones JB (2012). Avirulence proteins AvrBs7 from // |
+ | |||
+ | Ronald PC, Staskawicz BJ (1988). The avirulence gene AVrBs1 from // | ||
+ | |||
+ | White FF, Potnis N, Jones JB, Koebnik R (2009). The type III effectors of // | ||
+ | |||
+ | White FF, Jones JB (2018). One effector at a time. Nature Plants 4: 134-135. DOI: [[https:// | ||
+ | |||
+ | ===== Further reading ===== | ||
+ | |||
+ | Thieme F (2006). Genombasierte Identifizierung neuer potentieller Virulenzfaktoren von // | ||
- | White FF, Potnis N, Jones JB, Koebnik R (2009). The type III effectors | + | Thieme F, Koebnik R, Bekel T, Berger C, Boch J, Büttner D, Caldana C, Gaigalat L, Goesmann A, Kay S, Kirchner O, Lanz C, Linke B, McHardy AC, Meyer F, Mittenhuber G, Nies DH, Niesbach-Klösgen U, Patschkowski T, Rückert C, Rupp O, Schneiker S, Schuster SC, Vorhölter FJ, Weber E, Pühler A, Bonas U, Bartels D, Kaiser O (2005). Insights into genome plasticity and pathogenicity |